• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Adeno-associated virus vector expressing human iduronate-2-sulfatase
Date Designated: 03/28/2023
Orphan Designation: Treatment of mucopolysaccharidosis (MPS) II, also called Hunter syndrome
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
NeuroGT, Inc.
510 Meadowmont Village Circle #289
Chapel Hill, North Carolina 27517
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-